Charles River Laboratories (CRL) is up 4.4% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver is continued bullish follow-through from the company’s late-September investor day, where management reaffirmed 2026 guidance and outlined stronger long-term growth and margin targets. With third-quarter results scheduled for November 4, investors also appear to be positioning for another update after several recent strategic and digital-execution announcements.
Details:
Sources:
Charles River Laboratories Investor Relations, SEC, Yahoo Finance
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CRL Insider Trading Activity
$CRL insiders have traded $CRL stock on the open market 20 times in the past 6 months. Of those trades, 1 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $CRL stock by insiders over the last 6 months:
- JAMES C FOSTER has made 0 purchases and 3 sales selling 137,294 shares for an estimated $34,844,875.
- SHANNON M PARISOTTO (CEVP, Disc & Safety Assessment) has made 0 purchases and 4 sales selling 11,780 shares for an estimated $3,268,045.
- BIRGIT GIRSHICK (Chief Executive Officer) sold 6,500 shares for an estimated $1,819,349
- MICHAEL GUNNAR KNELL (SVP, Finance and CAO) has made 0 purchases and 9 sales selling 6,645 shares for an estimated $1,730,249.
- VICTORIA L CREAMER (EVP & Chief People Officer) sold 4,179 shares for an estimated $1,083,029
- NANCY C ANDREWS sold 573 shares for an estimated $163,442
- GLENN COLEMAN (EVP & Chief Financial Officer) purchased 10 shares for an estimated $2,974
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CRL Hedge Fund Activity
We have seen 258 institutional investors add shares of $CRL stock to their portfolio, and 262 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 783,508 shares (+22.7%) to their portfolio in Q2 2026, for an estimated $177,691,779
- MACKENZIE FINANCIAL CORP removed 593,254 shares (-99.7%) from their portfolio in Q2 2026, for an estimated $134,544,074
- INVESCO LTD. added 587,533 shares (+24.5%) to their portfolio in Q2 2026, for an estimated $133,246,609
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 467,663 shares (+inf%) to their portfolio in Q2 2026, for an estimated $106,061,291
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 458,472 shares (-62.2%) from their portfolio in Q2 2026, for an estimated $103,976,864
- MILLENNIUM MANAGEMENT LLC removed 447,583 shares (-47.9%) from their portfolio in Q2 2026, for an estimated $101,507,348
- D. E. SHAW & CO., INC. removed 399,541 shares (-92.7%) from their portfolio in Q2 2026, for an estimated $90,611,903
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CRL Price Targets
Multiple analysts have issued price targets for $CRL recently. We have seen 4 analysts offer price targets for $CRL in the last 6 months, with a median target of $220.0.
Here are some recent targets:
- Ricky Goldwasser from Morgan Stanley set a target price of $260.0 on 07/09/2026
- Michael Luo from CLSA set a target price of $219.0 on 05/29/2026
- Ross Muken from Evercore ISI Group set a target price of $220.0 on 05/08/2026
- Luke Sergott from Barclays set a target price of $220.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
